264 related articles for article (PubMed ID: 25555319)
21. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
Lin J; Lingohr-Smith M; Kwong WJ
J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
[TBL] [Abstract][Full Text] [Related]
22. Rate and duration of hospitalization for deep vein thrombosis and pulmonary embolism in real-world clinical practice.
Dentali F; Di Micco G; Giorgi Pierfranceschi M; Gussoni G; Barillari G; Amitrano M; Fontanella A; Lodigiani C; Guida A; Visonà A; Monreal M; Di Micco P
Ann Med; 2015; 47(7):546-54. PubMed ID: 26422329
[TBL] [Abstract][Full Text] [Related]
23. Adherence to Anticoagulant Therapy in Pediatric Patients Hospitalized With Pulmonary Embolism or Deep Vein Thrombosis: A Retrospective Cohort Study.
Singh RR; Gupte-Singh KR; Wilson JP; Moffett BS
Clin Appl Thromb Hemost; 2016 Apr; 22(3):260-4. PubMed ID: 26311289
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis.
Di Minno MN; Ambrosino P; Ambrosini F; Tremoli E; Di Minno G; Dentali F
J Thromb Haemost; 2016 May; 14(5):964-72. PubMed ID: 26845754
[TBL] [Abstract][Full Text] [Related]
25. Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients.
Ollendorf DA; Vera-Llonch M; Oster G
Am J Health Syst Pharm; 2002 Sep; 59(18):1750-4. PubMed ID: 12298113
[TBL] [Abstract][Full Text] [Related]
26. Reduction in the length of stay with rivaroxaban as a single-drug regimen for the treatment of deep vein thrombosis and pulmonary embolism.
van Bellen B; Bamber L; Correa de Carvalho F; Prins M; Wang M; Lensing AW
Curr Med Res Opin; 2014 May; 30(5):829-37. PubMed ID: 24432872
[TBL] [Abstract][Full Text] [Related]
27. Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions.
Margolis JM; Deitelzweig S; Kline J; Tran O; Smith DM; Bookhart B; Crivera C; Schein J
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792638
[TBL] [Abstract][Full Text] [Related]
28. Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study.
Schellong S; Ageno W; Casella IB; Chee KH; Schulman S; Singer DE; Desch M; Tang W; Voccia I; Zint K; Goldhaber SZ
Semin Thromb Hemost; 2022 Jun; 48(4):446-458. PubMed ID: 33971682
[TBL] [Abstract][Full Text] [Related]
29. Receipt of anticoagulation after venous thromboembolism diagnoses during delivery hospitalizations.
O'Shaugnessy F; Syeda SK; Huang Y; D'Alton ME; Wen T; Wright JD; Friedman AM
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6353-6355. PubMed ID: 33855935
[TBL] [Abstract][Full Text] [Related]
30. The effect of deep venous thrombosis on short-term outcomes and cost of care after head and neck cancer surgery.
Hennessey P; Semenov YR; Gourin CG
Laryngoscope; 2012 Oct; 122(10):2199-204. PubMed ID: 22865644
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory bowel disease increases the risks of deep vein thrombosis and pulmonary embolism in the hospitalized patients: a nationwide cohort study.
Chung WS; Lin CL; Hsu WH; Kao CH
Thromb Res; 2015 Mar; 135(3):492-6. PubMed ID: 25596768
[TBL] [Abstract][Full Text] [Related]
32. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
Bell GK; Goldhaber SZ
Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
[TBL] [Abstract][Full Text] [Related]
33. Real-world rates of in-hospital and postdischarge deep-vein thrombosis and pulmonary embolism in at-risk medical patients in the United States.
Amin AN; Lin J; Thompson S; Wiederkehr D
Clin Appl Thromb Hemost; 2011; 17(6):611-9. PubMed ID: 21593021
[TBL] [Abstract][Full Text] [Related]
34. Different characteristics and prognostic impact of deep-vein thrombosis / pulmonary embolism and intraabdominal venous thrombosis in colorectal cancer patients.
Choi S; Lee KW; Bang SM; Kim S; Lee JO; Kim YJ; Kim JH; Park YS; Kim DW; Kang SB; Kim JS; Oh D; Lee JS
Thromb Haemost; 2011 Dec; 106(6):1084-94. PubMed ID: 22072215
[TBL] [Abstract][Full Text] [Related]
35. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.
Bernstein CN; Blanchard JF; Houston DS; Wajda A
Thromb Haemost; 2001 Mar; 85(3):430-4. PubMed ID: 11307809
[TBL] [Abstract][Full Text] [Related]
36. Treatment, monitoring, and economic outcomes of venous thromboembolism among hospitalized patients in China.
Wu EQ; Xie J; Wu C; Du EX; Li N; Tan R; Liu Y
Pharmacoeconomics; 2014 Mar; 32(3):305-13. PubMed ID: 24500859
[TBL] [Abstract][Full Text] [Related]
37. Increased risk of deep vein thrombosis and pulmonary thromboembolism in patients with spinal cord injury: a nationwide cohort prospective study.
Chung WS; Lin CL; Chang SN; Chung HA; Sung FC; Kao CH
Thromb Res; 2014 Apr; 133(4):579-84. PubMed ID: 24457145
[TBL] [Abstract][Full Text] [Related]
38. Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data.
van Leent MW; Stevanović J; Jansman FG; Beinema MJ; Brouwers JR; Postma MJ
PLoS One; 2015; 10(8):e0135054. PubMed ID: 26241880
[TBL] [Abstract][Full Text] [Related]
39. Daily costs of hospitalization in non-valvular atrial fibrillation patients treated with anticoagulant therapy.
Dasta JF; Pilon D; Mody SH; Lopatto J; Laliberté F; Germain G; Bookhart BK; Lefebvre P; Nutescu EA
J Med Econ; 2015; 18(12):1041-9. PubMed ID: 26201251
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary embolism without deep venous thrombosis: De novo or missed deep venous thrombosis?
Van Gent JM; Zander AL; Olson EJ; Shackford SR; Dunne CE; Sise CB; Badiee J; Schechter MS; Sise MJ
J Trauma Acute Care Surg; 2014 May; 76(5):1270-4. PubMed ID: 24747459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
